Tierney David S

Average Profitability
8.21%
Insider Buys Quantity
3
Insider Buys Sum
$65,172.00
Insider Sells Quantity
7
Insider Sells Sum
$2.61M

Insider Activity of Tierney David S

According to the SEC Form 4 filings, Tierney David S, being in a position of

  1. director at Catalyst Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 90000 shares for $1.36M,
    over all time since 2009-03-06, has bought 62000 shares for $65,172, and sold 260000 shares for $2.61M.

The largest purchase of all time was on 2013-10-23 and amounted to 16000 shares of Catalyst Pharmaceuticals, Inc. for $32,480.

The largest sale of all time was on 2023-12-12 and amounted to 50000 shares of Catalyst Pharmaceuticals, Inc. for $666,250.

Biography of Tierney David S

No biography is available at this moment.

2024-08-21SaleCatalyst Pharmaceuticals, Inc.
CPRX
director
15,000
0.0124%
$20.10$301,455-0.15%
2024-04-08SaleCatalyst Pharmaceuticals, Inc.
CPRX
director
25,000
0.0214%
$15.68$392,000+9.29%
2023-12-12SaleCatalyst Pharmaceuticals, Inc.
CPRX
director
50,000
0.0468%
$13.32$666,250+20.68%
2023-04-05SaleCatalyst Pharmaceuticals, Inc.
CPRX
director
30,000
0.0283%
$16.83$504,900-18.07%
2022-08-22SaleCatalyst Pharmaceuticals, Inc.
CPRX
20,000
0.0192%
$14.16$283,180+4.82%
2022-05-20SaleCatalyst Pharmaceuticals, Inc.
CPRX
20,000
$0$0+110.91%
2021-08-13SaleCatalyst Pharmaceuticals, Inc.
CPRX
director
100,000
0.0738%
$4.60$459,895+15.23%
2013-10-23PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
16,000
0.0298%
$2.03$32,480+8.21%
2012-05-29PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
40,000
0.1575%
$0.58$23,392+3.64%
2009-03-06PurchaseCatalyst Pharmaceuticals, Inc.
CPRX
director
6,000
0.0529%
$1.55$9,300-44%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.